Atrás
19
32
42
62
41
44
43
Rango del Día
$23.21
$23.81
Rango de 52 Semanas
$19.05
$26.58
Volumen
926,327
Promedio 50D / 200D
$23.91
/
$22.27
Cierre Anterior
$23.07
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 13.7 | 0.2 |
| P/B | 3.1 | 3.0 |
| ROE % | 25.5 | 3.6 |
| Net Margin % | 36.4 | 3.8 |
| Rev Growth 5Y % | 43.0 | 9.9 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$33.00
+38.7%
P/E Futuro
12.88
EPS Futuro
$1.85
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
630.63M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$2.70
$2.57 – $2.78
|
894.35M | 1 |
| FY2029 |
$2.50
$2.38 – $2.57
|
843.73M | 1 |
| FY2028 |
$2.24
$1.89 – $2.58
|
765.93M | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | $0.42 | $0.68 | +61.9% |
| 2025-11-05 | $0.51 | $0.68 | +33.3% |
| 2025-08-06 | $0.58 | $0.68 | +17.2% |
| 2025-05-07 | $0.53 | $0.68 | +28.3% |
| 2025-02-26 | $0.32 | $0.70 | +118.8% |
| 2024-11-06 | $0.49 | $0.57 | +16.3% |
| 2024-08-07 | $0.42 | $0.56 | +33.3% |
| 2024-05-08 | $0.34 | $0.38 | +11.8% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue grew 43.00% annually over 5 years — strong growth
Earnings grew 30.78% over the past year
ROE of 25.49% indicates high profitability
Net margin of 36.39% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 208.61M in free cash flow
Crecimiento
Revenue Growth (5Y)
43.00%
Revenue (1Y)19.78%
Earnings (1Y)30.78%
FCF Growth (3Y)83.64%
Calidad
Return on Equity
25.49%
ROIC20.20%
Net Margin36.39%
Op. Margin43.77%
Seguridad
Debt / Equity
0.00
Current Ratio6.08
Interest Coverage0.00
Valoración
P/E Ratio
13.65
Forward P/E12.88
P/B Ratio3.07
EV/EBITDA8.61
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.78% | Revenue Growth (3Y) | 21.62% |
| Earnings Growth (1Y) | 30.78% | Earnings Growth (3Y) | 73.24% |
| Revenue Growth (5Y) | 43.00% | Earnings Growth (5Y) | 52.64% |
| Profitability | |||
| Revenue (TTM) | 588.99M | Net Income (TTM) | 214.33M |
| ROE | 25.49% | ROA | 19.36% |
| Gross Margin | 85.19% | Operating Margin | 43.77% |
| Net Margin | 36.39% | Free Cash Flow (TTM) | 208.61M |
| ROIC | 20.20% | FCF Growth (3Y) | 83.64% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 6.08 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 13.65 | Forward P/E | 12.88 |
| P/B Ratio | 3.07 | P/S Ratio | 4.97 |
| PEG Ratio | 0.50 | Forward PEG | N/A |
| EV/EBITDA | 8.61 | Fwd EV/EBITDA | 8.09 |
| Forward P/S | 4.64 | Fwd Earnings Yield | 7.76% |
| FCF Yield | 7.13% | ||
| Market Cap | 2.93B | Enterprise Value | 2.22B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 588.99M | 491.73M | 398.20M | 214.20M | 140.83M |
| Net Income | 214.33M | 163.89M | 71.41M | 83.08M | 39.48M |
| EPS (Diluted) | 1.68 | 1.31 | 0.63 | 0.75 | 0.37 |
| Gross Profit | 501.74M | 422.89M | 346.24M | 179.81M | 118.95M |
| Operating Income | 257.78M | 195.12M | 86.81M | 101.84M | 52.39M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.11B | 851.41M | 470.11M | 375.63M | 237.79M |
| Total Liabilities | 152.54M | 123.78M | 82.23M | 75.21M | 30.96M |
| Shareholders' Equity | 954.27M | 727.63M | 387.88M | 300.42M | 206.83M |
| Total Debt | 2.79M | 3.19M | 3.56M | 3.89M | 4.20M |
| Cash & Equivalents | 709.17M | 517.55M | 137.64M | 298.40M | 171.45M |
| Current Assets | 894.03M | 623.61M | 219.33M | 320.81M | 210.11M |
| Current Liabilities | 147.15M | 120.68M | 76.06M | 57.59M | 27.06M |
Puntuaciones de Estrategias
This stock passed the criteria for 7 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#995 of 1049
Custom
Capital Light Compounder
#152 of 220
#116 of 158
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#87 of 328
#68 of 203
Custom
Balanced Risk
#89 of 153
Custom
Lower Risk
#79 of 141
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Capital Light Compounder
Mar 24, 2026
Entró
Growth Investing (Philip Fisher)
Mar 24, 2026
Entró
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Entró
Value Investing (Warren Buffett)
Mar 24, 2026
Entró
Balanced Risk
Mar 24, 2026
Entró
Lower Risk
Mar 24, 2026